Senate Finance Chair Ron Wyden (D-OR) (Francis Chung/E&E News/POLITICO via AP Images)

Sen­ate Fi­nance chair goes af­ter Am­gen again on US tax­es, ask­ing for pay­ment specifics

Sen­ate Fi­nance Chair Ron Wyden is ask­ing Am­gen again for more in­for­ma­tion on its fi­nan­cials as he con­tin­ues to dig in­to the way phar­ma com­pa­nies use sub­sidiaries in low- or ze­ro-tax coun­tries to low­er their bills.

The De­mo­c­rat sen­a­tor from Ore­gon said to­day that he sent Am­gen a fi­nal re­quest for “vol­un­tary com­pli­ance” to pro­vide spe­cif­ic in­for­ma­tion on Am­gen’s fi­nan­cials. The let­ter, ad­dressed to Am­gen CEO Robert Brad­way, asked him to ex­plain how Am­gen paid a low­er tax rate than the stan­dard cor­po­rate tax rate in the US of 21%.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.